Reply to M.L. Friedlander et al.
David R
DR
Spriggs
D004317:Doxorubicin / Q000031:analogs & derivatives*; D034261:Epothilones / Q000627:therapeutic use*; D005185:Fallopian Tube Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010534:Peritoneal Neoplasms / Q000188:drug therapy*; D011092:Polyethylene Glycols / Q000627:therapeutic use*
D034261:Epothilones; D011092:Polyethylene Glycols; D004317:Doxorubicin